gila monster venom semaglutide The toxic bite of a can kill a human, but a specific ingredient in the cocktail of the lizard's is the reason we have glucagon-like peptide (GLP-1) agonists like Ozempic Literally Came From a

Why it matters: Pfizer, the company developing berobenatide, is now recruiting people for larger phase 3 trials, including one focused on people with type 2 diabetes, where participants take weekly injections of berobenatide

Those focusing on muscle recovery

Neurotoxic protein oligomerswhat you see is not always what you get

The abdomen is often preferred because it is easy to access and allows for multiple injection points that can be rotated throughout treatment

Complex formulations that are difficult to replicate controlled-release systems, transdermal patches, sterile injectables can delay generic entry by 12 to 24 months beyond compound patent expiry, because generic companies need time to demonstrate bioequivalence through clinical studies